Beruflich Dokumente
Kultur Dokumente
BY
DR OJULE J D
Department of Obstetrics and Gynaecology,
UPTH
INTRODUCTION / PREAMBLE
Hypertensive dx occurs in approximately 12-22%
of pregnancies. It is the most common medical
disorder of Pregnancy.
10/14/08 OJULE J D 3
It varies from mild to severe disease, to
eclampsia.
Aetiology is still largely unknown, with but
though to be a mulifactorial interplay play of
genetic, hormonal and environmental factors.
Trials on prevention have also been largely
disappointing and mainstay of RX have been
integrated ANC and access to monitoring
services.
Mgt is ideally collaborative – the obstetrician
the physician, laboratory scientists, Physician,
Radiologist and the Neonatologist.
Definitive RX is delivery of baby / placenta.
10/14/08 OJULE J D 4
Definition of terms
Hypertension
Systemic Bp ≥ 140/90 mmHg on ≥ 2 occasions
at least 4-6 hours apart
Increase SBp ≥ 30 mmHg, D Bp ≥ 1 5 mmHg
over booking BP
Single DBP ≥ 110 mmHg
Mean arterial pressure MAP ≥ 20 mmHg over
the booking value.
Mean arterial pressure ≥ 105 mmHg.
MAP = Diastolic Bp + (1/3 pulse pressure)
Pulse pressure = systolic Bp – Diastolic BP)
10/14/08 OJULE J D 5
Proteinuria
≥ 300mg of protein in a 24 hr urine sample
≥1g/L (clean catch / catheter urine on 2 or more
occasions) = 2 + proteinuria.
Severe proteinuria = 5g/L 24 hrs urine sample
Chronic Hypertension
Persistent elevation in blood pressure of 140/90
mmHg or greater before 20 weeks of gestation
or persistent hypertension beyond 6 weeks post
partum.
Essential –cause unknown
10/14/08 OJULE J D 6
PIH
Hypertension and or proteinuria developing after
20 weeks of presenting, during labour or the
puerperuim in previously normotensive
nonprotenuric woman subdivided into
PIH (without proteinuria) – gestational hypertension
Pregnancy induced protenuria – (without
hypertension)
Pregnancy induced – proteinuric - hypertension
10/14/08 OJULE J D 7
PRE-ECLAMPSIA
10/14/08 OJULE J D 8
AETIOPATHOGENSIS OF PRE-
ECLAMPSIA
Now thought to be a multifactorial interplay of genetic,
hormonal, immunological, and environmental factors
which leads to
Release of factor X from the placenta which causes
Relative lack of trophoblastic invasion of the spiral arterial
walls during placentation which - to uteroplacenta
insusfficiency – placenta ischemia and hypoxia.
Activation of neutrophils and production of reactive 02 Spp
and lipid peroxidase - acute atherosis (aggregates of fibrin,
platelets and lipophages – partially or completely blocking the
arterioles.
10/14/08 OJULE J D 9
The damaged endothetial cells lead to
Reduce PGI2 production – vasodilator and
antiplatelet aggregator
Increased platelet activation – increased
TXA2 (vasoconstrictor/vasospasm
Increased sensitivity to vasoactive
substances – vasospasm
Increased leaky capillaries – fluid retention
Increase TPR
10/14/08 OJULE J D 10
Microangiopathic haemolysis
Glomerular endotheliosis – proteinuria,
decreased uric acid, GFR, reduced renal blood
flow.
Focal cerebral Spasm – abn. Electrical activity
Focal parenchymal necrosis –increase LFT ,
hepatic capsule distension.
These changes can progress to cause
decompensation of one or more systems.
The maternal response to these changes modify
the way the dx manifest, the severity of signs and
symptoms and the outcome for mother and child.
10/14/08 OJULE J D 11
Risk factors
Genetic
Women whose mothers had pre-eclampsia
have a 20-25% risk
In women with a sister with a history of pre-
eclampsia risk may be as high as 35-40%
10/14/08 OJULE J D 12
Obstetric risk factors
Primiparity
Multiple gestation
Primipaternity/Pregnancy for a new consort
Previous pre-eclampsia
Hydrops with a large placenta
Hydatidiform mole
10/14/08 OJULE J D 13
Medical risk factors
Pre-existing hypertension
Renal disease
Diabetes(pre-existing or gestational)
Antiphospholipid syndrome
Connective tissue diseases
10/14/08 OJULE J D 14
Classification
Mild pre-eclampsia- asymptomatic
-Cerebral manifestations;
headache
dizziness
drowsiness
tinnitus
- visual disturbances
10/14/08 OJULE J D 15
Severe Pre-eclampsia/imminent
eclampsia
Visual disturbances
Diplopia
blurred vision
scotomata
Gastrointestinal
Nausea
Vomitting
Haematemesis
Epigastric pain/Tenderness
Renal
Oliguria
Haematuria
Haemaoglobinuria
Anuria
10/14/08 OJULE J D 16
Cardiovascular
Oedema
Severe hypertension
Respiratory
Cyanosis
Pulmonary oedema
Foetal
IUGR
10/14/08 OJULE J D 17
INVESTIGATIONS
FBC + Platelets
Serum E/U/Cr
Uric acid (≥ 6mg/dl)
FBS
LFT – AST, ALT, LDH (1000iu/L)
Clotting profile
Urinalysis
USS
10/14/08 OJULE J D 18
Predictive Test
Roll-over test
+ roll over test -≥ 20mmHg increase in DBp
when measured 5 minutes afer gravida is rolled
from the lat. To supine position between 28-32
weeks gestation.
Not sufficiently reliable, sensitive and specific.
10/14/08 OJULE J D 19
Angiotensin II test
A normal pregnant patient requires mean
angiotensin II dose of 13.5 – 14.9 ng/kg/min to
increase DBp by 20 mmHg.
Normotensive primigravidae destined to develop
PE respond at < 8ng/kg/min as early as 28 – 32
weeks. 90% of these patients will subsequently
develop PE.
10/14/08 OJULE J D 20
COMPLICATIONS
FOETAL
Oligohydramnios
IUGR
Prematurity
IUFD
MATERNAL
Eclampsia
CVD
Cortical blindness
HELLP syndrome
Hepatic rupture
Renal failure
Pulmonary oedema
Maternal death
10/14/08 OJULE J D 21
Thank
you
for
Listening
10/14/08 OJULE J D 22